Asia Pacific Musculoskeletal Msk Disease Management Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
|
 CAGR |
% |
| Major Markets Players |
亚太肌肉骨骼 (MSK) 疾病管理市场，按类型（数字生物反馈系统、以肌肉骨骼为重点的数字应用程序、解决方案及其他）、技术（精密运动技术、计算机视觉技术及其他技术）、集成类型（手机、平板电脑、计算机及其他）、方式（虚拟疗法、面对面疗法、定制/个性化疗法及其他）、应用（术前应用和术后应用）、患者人群（儿科、成人和老年病学）、最终用户（医院和诊所、疗养院、健康中心、康复中心、虚拟/家庭保健环境及其他）划分 - 行业趋势和预测到 2030 年。
亚太地区肌肉骨骼 (MSK) 疾病管理市场分析与洞察
对 MSK 疾病诊断技术进步的需求不断增加、对 MSK 疾病的认识不断提高、类风湿性关节炎 (RA) 患病率不断上升以及骨折病例不断增加是预计推动市场增长的因素。
另一方面，市场参与者的战略举措、产品开发、远程医疗在 MSK 疾病管理中的应用以及 MDA 和家庭医疗保健在 MSK 疾病管理中的应用增加可能成为市场增长的机会。
然而，骨科疾病诊断和治疗的高成本以及治疗 MSK 疼痛的重型药物的使用增加预计将抑制市场的增长。
药物开发和设计中对 MSK 疾病管理的需求不断增长，预计将推动亚太地区市场增长。Data Bridge Market Research 分析称，在 2023 年至 2030 年的预测期内，亚太地区肌肉骨骼 (MSK) 疾病管理市场将以 24.3% 的复合年增长率增长。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史年份 |
2021 年（可定制至 2023 年 - 2030 年） |
|
定量单位 |
收入（百万美元），定价（美元） |
|
涵盖的领域 |
按类型（数字生物反馈系统、肌肉骨骼重点数字应用程序、解决方案及其他）、技术（精密运动技术、计算机视觉技术及其他技术）、集成类型（手机、平板电脑、计算机及其他）、方式（虚拟疗法、面对面疗法、定制/个性化疗法及其他）、应用（术前应用和术后应用）、患者人群（儿科、成人和老年病学）、最终用户（医院和诊所、疗养院、健康中心、康复中心、虚拟/家庭保健环境及其他） |
|
覆盖国家 |
中国、日本、印度、韩国、新加坡、泰国、越南、台湾、马来西亚、新西兰、澳大利亚、菲律宾、印度尼西亚和亚太地区其他地区 |
|
涵盖的市场参与者 |
RecoveryOne、Kiio、Omada Health Inc.、DarioHealth Corp.、IncludeHealth、kaia health、IMC.、Wellness Coaches USA, LLC、Sparta Science、Movement RX、Phzio、Airrosti Rehab Center, LLC、SimpleTherapy, Inc.、Hinge Health, Inc.、Sword Health, Inc.、SPRITE HEALTH 和 Limber Health, Inc. 等 |
市场定义
肌肉骨骼 (MSK) 疾病或损伤包括 150 多种不同的疾病或病症，它们会从内部影响人体系统，其特征是肌肉、骨骼、关节和邻近结缔组织的缺陷，导致终身无法正常运作和参与。这些病症的特征是疼痛、步态运动和灵活性受限，从而降低了人们工作和参与社会的能力。
MSK 疾病的管理包括咨询医生，并结合远程医疗，即使用数字生物反馈系统 (DBS)、MDA 和疗法。体育锻炼和体重管理计划也是关节炎患者重要的自我管理活动。虚拟治疗或远程咨询需要采取整体方法，在 MSK 实践中实施视频会议和电话咨询。
- 在不久的将来，与 MSK 疾病管理相关的身体运动和术后应用的重要决策将由那些不仅了解远程医疗和虚拟技术，而且还能使用 MSK 疾病管理工具及其发布的知识来制定假设和确定质量目标的个人来做出。
亚太地区肌肉骨骼 (MSK) 疾病管理市场动态
驱动程序
- 肌肉骨骼疾病诊断技术进步（MSDS）
肌肉骨骼 (MSK) 疾病是影响 MSK 系统中人体运动的损伤和疾病，例如肌肉、韧带、神经、肌腱、软骨和椎间盘。一些常见的 MSK 疾病包括重症肌无力、骨关节炎 (OA)、痛风、类风湿性关节炎、背痛、骨质疏松症和系统性红斑狼疮 (SLE)。MSK 疼痛有多种原因，例如，肌肉组织可能因日常活动中的磨损而受损。扭伤、车祸、跌倒、急促运动、骨折、脱臼和直接肌肉打击对人体部位造成的压力也会导致 MSK 疼痛。
- 骨折病例增加
骨折是骨折的医学定义。骨折通常是跌倒、车祸或运动损伤等伤害的结果。但是，某些疾病和重复性力量（如跑步）会增加某些类型骨折的风险。如果骨骼承受的压力超过其承受能力，就会开裂或断裂。任何大小的骨折都称为骨折。如果骨折刺穿皮肤，则称为开放性骨折（复合骨折）。应力性骨折是由于骨骼受到反复或长时间的力量而导致的骨折。反复的压力会削弱骨骼，直至最终断裂。
机会
- 远程医疗在肌肉骨骼 (MSK) 疾病管理中的应用
远程医疗为患者提供经济实惠的优质护理。预诊计划可适当实施远程医疗，确保为患者和医生提供功能齐全的远程医疗设备。治疗 MSK 疾病的医生通过远程医疗进行结构化的 MSK 检查。使用常见的家用物品，医生可以复制现场临床检查操作。家庭护理指导和在线康复可提供治疗的初步管理。
- 主要市场参与者的战略举措
肌肉骨骼 (MSK) 疾病的增加增加了对战略商业理念的需求。它包括伙伴关系、业务扩展、协作和其他发展。在亚太肌肉骨骼 (MSK) 疾病管理市场中，许多健康机构和市场参与者都采取了旨在为客户带来投资回报的举措。计划中的战略使市场参与者能够与组织的职能活动保持一致，以实现既定目标。它指导公司的讨论和决策，以确定实现目标所需的资源和预算，从而提高运营效率。
限制/挑战
- 骨科疾病诊疗费用高
慢性骨科疾病（如关节炎和滑囊炎）会影响 MSK 系统，最常见的是骨骼或关节。它们会引起疼痛和功能障碍，使正常的日常活动变得困难。这些疾病不同于骨科损伤，例如肩关节脱臼或骨折，后者通常是由突然的创伤引起的。与意外或创伤性骨科损伤不同，慢性疾病通常是渐进性的，开始时缓慢，随着时间的推移而恶化或发展。它们可能是遗传或与年龄有关的，也可能是由过度使用引起的。
有些骨科疾病是可以治愈的，有些目前无法治愈，但可以通过治疗来减轻疼痛并改善生活质量。准确的诊断和有针对性的治疗可以帮助减少问题，即使是在没有治疗的情况下病情恶化。治疗建议取决于病情的类型和严重程度。治疗方法包括从 RICE（休息、冰敷、加压和抬高）到大型手术。
- 重型药物在治疗 MSK 疼痛中的使用量增加
MSK 疼痛对患者和医生来说都是一种具有挑战性的疾病。许多成年人，无论年龄、性别或经济状况如何，在一生中的某个时刻都经历过一次或多次 MSK 疼痛。它影响了大约 47% 的人口。其中约 39% 至 45% 是需要医生咨询的长期问题。治疗不当的 MSK 疼痛会降低生活质量并导致严重的社会经济问题。
多模式镇痛和多学科方法是有效治疗 MSK 疼痛的关键要素。药物、非药物和介入性疼痛管理对于改善患者的康复、健康和生活质量都很重要。因此，最近的指南建议采取预防策略和物理工具来减少药物使用。对于对治疗反应不佳的患者，适当使用介入性疼痛管理和其他替代技术对于安全有效地治疗慢性疼痛患者至关重要。
后 COVID-19 对亚太地区肌肉骨骼 (MSK) 疾病管理市场的影响
疫情期间，MSK 病管理的症状在 COVID-19 康复后仍然存在，最常见的症状包括疲劳、背痛、关节痛、肌痛、腰痛和颈痛。MSK 病管理增加了虚拟治疗远程医疗和数字康复服务的使用。
在 COVID-19 疫情环境下，远程医疗对于医疗服务提供者来说是可行的，可以为患有各种 MSK 疾病的患者提供康复服务。目前的证据表明，对于某些 MSK 疾病，远程医疗评估可能可靠，治疗可能有效，患者满意度可能比门诊护理更好。
最新动态
- 2022 年 4 月，Airrosti Rehab Center, LLC 与 Buoy Health 的创新医疗市场建立了合作伙伴关系。此次合作旨在为 Buoy 每月超过 200 万用户提供物有所值的 MSK 护理，并开发新颖的 MSK 虚拟产品。
- 2022年3月，DarioHealth Corp.与Sanofi US达成了合同协议，该协议重点是加速DarioHealth Corp.在MSK疾病管理数字产品组合中的商业增长以及在DarioHealth Corp.平台上开发数字健康解决方案。
亚太地区肌肉骨骼 (MSK) 疾病管理市场范围
亚太地区肌肉骨骼 (MSK) 疾病管理市场根据类型、技术、集成类型、模式、应用、患者人群和最终用户细分为七个重要细分市场。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
类型
- 数字生物反馈系统
- 以肌肉骨骼为重点的数字应用程序 (MDAS)
- 解决方案
- 其他的
根据类型，市场细分为数字生物反馈系统、肌肉骨骼重点数字应用程序 (MDA)、解决方案和其他。
技术
- 精密运动技术
- 计算机视觉技术
- 其他技术
根据技术，市场细分为精密运动技术、计算机视觉技术和其他技术。
集成类型
- 电话
- 药片
- 电脑
- 其他的
根据集成类型，市场细分为手机、平板电脑、计算机和其他
情态
- 虚拟治疗
- 面对面治疗
- 定制/个性化治疗
- 其他的
根据治疗方式，市场分为虚拟治疗、面对面治疗、定制/个性化治疗和其他治疗。
应用
- 术前应用
- 术后应用
根据应用，市场分为手术前应用和手术后应用。
患者人群
- 儿科
- 成年人
- 老年病学
根据患者群体，市场分为儿科、成人和老年病学。
最终用户
- 医院和诊所
- 养老院
- 健康中心
- 康复中心
- 虚拟/家庭医疗保健设置
- 其他的
根据最终用户，市场分为医院和诊所、疗养院、健康中心、康复中心、虚拟/家庭医疗保健机构等。
亚太地区肌肉骨骼 (MSK) 疾病管理市场区域分析/见解
对亚太地区肌肉骨骼 (MSK) 疾病管理市场进行分析，并按地区、类型、技术、集成类型、方式、应用、患者群体和最终用户提供市场规模洞察和趋势。
本市场报告涵盖的国家包括中国、日本、印度、韩国、新加坡、泰国、越南、台湾、马来西亚、新西兰、澳大利亚、菲律宾、印度尼西亚和亚太地区其他地区。由于骨折病例数量不断增加，预计中国将实现丰厚的增长。
报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了亚太品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战，以及对销售渠道的影响。
竞争格局和亚太地区肌肉骨骼 (MSK) 疾病管理市场份额分析
亚太地区肌肉骨骼 (MSK) 疾病管理市场竞争格局提供了有关竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、亚太地区业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
亚太地区肌肉骨骼 (MSK) 疾病管理市场的一些主要参与者包括 RecoveryOne、Kiio、Omada Health Inc.、DarioHealth Corp.、IncludeHealth、kaia health、IMC.、Wellness Coaches USA, LLC、Sparta Science、Movement RX、Phzio、Airrosti Rehab Center, LLC、SimpleTherapy, Inc.、Hinge Health, Inc.、Sword Health, Inc.、SPRITE HEALTH 和 Limber Health, Inc. 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 TYPE SEGMENT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 THE CATEGORY VS TIME GRID
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCE
4.3 KEY STRATEGIC INITIATIVES
4.4 EMERGING TREND ANALYSIS OF DIGITAL REHABILITATION AND DIGITAL PHYSIOTHERAPY IN THE ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET
4.4.1 DIGITAL REHABILITATION
4.4.2 DIGITAL PHYSIOTHERAPY
5 EPIDEMOLOGY
5.1 US
5.2 CANADA
5.3 MEXICO
5.4 GERMANY
5.5 FRANCE
5.6 U.K.
5.7 ITALY
5.8 SPAIN
5.9 RUSSIA
5.1 TURKEY
5.11 BELGIUM
5.12 DENMARK
5.13 NETHERLANDS
5.14 SWITZERLAND
5.15 SWEDEN
5.16 POLAND
5.17 NORWAY
5.18 FINLAND
5.19 CHINA
5.2 JAPAN
5.21 SOUTH KOREA
5.22 INDIA
5.23 AUSTRALIA
5.24 NEW ZEALAND
5.25 SINGAPORE
5.26 THAILAND
5.27 MALAYSIA
5.28 VIETNAM
5.29 TAIWAN
5.3 INDONESIA
5.31 PHILIPPINES
5.32 BRAZIL
5.33 ARGENTINA
5.34 SOUTH AFRICA
5.35 SAUDI ARABIA
5.36 BAHRAIN
5.37 U.A.E
5.38 KUWAIT
5.39 OMAN
5.4 QATAR
5.41 EGYPT
5.42 ISRAEL
6 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 TECHNOLOGICAL ADVANCES IN THE DIAGNOSIS OF MUSCULOSKELETAL DISORDERS (MSDS)
7.1.2 RISING AWARENESS ABOUT MUSCULOSKELETAL DISORDERS (MSDS)
7.1.3 GROWING PREVALENCE OF RHEUMATOID ARTHRITIS (RA)
7.1.4 INCREASING CASES OF BONE FRACTURES
7.2 RESTRAINTS
7.2.1 HIGH COST OF DIAGNOSIS AND TREATMENT OF ORTHOPEDIC DISEASES
7.2.2 RISE IN USE OF HEAVY-DUTY DRUGS IN TREATING MUSCULOSKELETAL (MSK) PAIN
7.3 OPPORTUNITIES
7.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.3.2 USE OF TELEMEDICINE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT
7.3.3 INCREASED USE OF MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) FOR MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT
7.3.4 USE OF HOME HEALTHCARE FOR MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT
7.4 CHALLENGES
7.4.1 CHALLENGES FACED BY PHYSICIANS WHILE TREATING ATHLETES WITH MUSCULOSKELETAL (MSK) DISEASES
7.4.2 STRICT REGULATORY GUIDELINES FOR MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT
8 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE
8.1 OVERVIEW
8.2 DIGITAL BIOFEEDBACK SYSTEM
8.3 MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS)
8.3.1 IOS-SYSTEMS
8.3.2 ANDROID-SYSTEMS
8.3.3 OTHER SYSTEMS
8.4 SOLUTIONS
8.4.1 DIRECT SUPPORT
8.4.1.1 MULTIMODAL PAIN THERAPY
8.4.1.2 ONSITE PERSONALIZED THERAPY
8.4.1.3 SOLUTIONS TO REDUCE INJURIES
8.4.1.4 MIND-BODY CONNECTION IMPROVEMENT
8.4.1.5 EARLY PREVENTION AND INTERVENTION
8.4.1.6 PREVENTION, RECOVERY AND EDUCATION
8.4.1.7 PERSONALIZED PAIN RECOVERY
8.4.1.8 SENSOR-GUIDED EXERCISE THERAPY
8.4.1.9 TRAINING OF EDUCATION SKILLS
8.4.1.10 SELF-TRACKING OF PAIN EPISODES
8.4.1.11 RELAXATION TECHNIQUES
8.4.1.12 POST-OPERATIVE PAIN TRACKING
8.4.1.12.1 REAL-TIME MONITORING
8.4.1.12.2 SYMPTOM MANAGEMENT
8.4.1.13 OTHERS
8.4.2 PROGRESS TRACKING
8.4.3 OTHERS
8.5 OTHERS
9 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY
9.1 OVERVIEW
9.2 PRECISION MOTION TECHNOLOGY
9.3 COMPUTER MOTION TECHNOLOGY
9.4 OTHER TECHNOLOGIES
10 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE
10.1 OVERVIEW
10.2 PHONE
10.2.1 DIGITAL BIOFEEDBACK SYSTEM
10.2.2 MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS)
10.2.3 THERAPIES
10.2.4 OTHERS
10.3 TABLET
10.3.1 DIGITAL BIOFEEDBACK SYSTEM
10.3.2 MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS)
10.3.3 THERAPIES
10.3.4 OTHERS
10.4 COMPUTER
10.4.1 DIGITAL BIOFEEDBACK SYSTEM
10.4.2 MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS)
10.4.3 THERAPIES
10.4.4 OTHERS
10.5 OTHERS
11 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY
11.1 OVERVIEW
11.2 VIRTUAL THERAPY
11.2.1 INTERNET BASED
11.2.2 TELEPHONE BASED
11.2.3 MOBILE PHONE APPLICATION
11.2.4 INTERNET BASED WITH TELEPHONE SUPPORT
11.2.5 INTERACTIVE VOICE RESPONSE
11.2.6 VIDEO TELECONFERENCING
11.2.7 MOBILE PHONE APPLICATION WITH TELEPHONE SUPPORT
11.2.8 INTERACTIVE VOICE RESPONSE WITH TELEPHONE SUPPORT
11.2.9 INTERNET BASED WITH VIDEO CONFERENCING
11.2.10 INTERACTIVE VOICE RESPONSE WITH TELEPHONE SUPPORT AND INTERNET BASED
11.2.11 OTHERS
11.3 IN-PERSON THERAPY
11.4 CUSTOMIZED/ PERSONALIZED THERAPY
11.5 OTHERS
12 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 PRE-SURGERY APPLICATION
12.2.1 ANTERIOR CERVICAL DISCECTOMY AND FUSION SURGERY
12.2.2 ANTERIOR LUMBAR INTERBODY FUSION SURGERY
12.2.3 LATERAL LUMBAR INTERBODY FUSION SURGERY
12.2.4 INTERNET BASED WITH TELEPHONE SUPPORT
12.2.5 MINIMALLY INVASIVE SPINE SURGERY
12.2.6 MOTION PRESERVING SPINE SURGERY
12.2.7 POSTERIOR CERVICAL FUSION SURGERY
12.2.8 POSTERIOR LUMBAR INTERBODY FUSION SURGERY
12.2.9 SACROILIAC JOINT FUSION SURGERY
12.2.10 SCOLIOSIS CORRECTION SURGERY
12.2.11 VERTEBRAL AUGMENTATION SURGERY
12.2.12 FRACTURE FIXATION SURGERY
12.2.13 HIP SURGERY
12.2.13.1 TOTAL HIP REPLACEMENT
12.2.13.2 PARTIAL HIP REPLACEMENT
12.2.13.3 HIP RESURFACING
12.2.13.4 OTHERS
12.2.14 KNEE SURGERY
12.2.14.1 TOTAL KNEE REPLACEMENT
12.2.14.2 PARTIAL KNEE REPLACEMENT
12.2.14.3 MISS FUSION
12.2.14.4 OTHERS
12.3 POST-SURGERY APPLICATION
12.3.1 ANTERIOR CERVICAL DISCECTOMY AND FUSION SURGERY
12.3.2 ANTERIOR LUMBAR INTERBODY FUSION SURGERY
12.3.3 LATERAL LUMBAR INTERBODY FUSION SURGERY
12.3.4 INTERNET BASED WITH TELEPHONE SUPPORT
12.3.5 MINIMALLY INVASIVE SPINE SURGERY
12.3.6 MOTION PRESERVING SPINE SURGERY
12.3.7 POSTERIOR CERVICAL FUSION SURGERY
12.3.8 POSTERIOR LUMBAR INTERBODY FUSION SURGERY
12.3.9 SACROILIAC JOINT FUSION SURGERY
12.3.10 SCOLIOSIS CORRECTION SURGERY
12.3.11 VERTEBRAL AUGMENTATION SURGERY
12.3.12 FRACTURE FIXATION SURGERY
12.3.13 HIP SURGERY
12.3.13.1 TOTAL HIP REPLACEMENT
12.3.13.2 PARTIAL HIP REPLACEMENT
12.3.13.3 HIP RESURFACING
12.3.13.4 OTHERS
12.3.14 KNEE SURGERY
12.3.14.1 TOTAL KNEE REPLACEMENT
12.3.14.2 PARTIAL KNEE REPLACEMENT
12.3.14.3 MISS FUSION
12.3.14.4 OTHERS
13 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION
13.1 OVERVIEW
13.2 PEDIATRICS
13.2.1 MALE
13.2.2 FEMALE
13.3 ADULTS
13.3.1 MALE
13.3.2 FEMALE
13.4 GERIATRIC
13.4.1 MALE
13.4.2 FEMALE
14 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER
14.1 OVERVIEW
14.2 HOSPITALS & CLINICS
14.2.1 MULTIPLE
14.2.2 PHYSICAL THERAPIST
14.2.3 NURSE
14.2.4 HEALTH COACH
14.2.5 OTHERS
14.3 NURSING HOMES
14.3.1 MULTIPLE
14.3.2 PHYSICAL THERAPIST
14.3.3 NURSE
14.3.4 HEALTH COACH
14.3.5 OTHERS
14.4 HEALTH CENTERS
14.4.1 MULTIPLE
14.4.2 PHYSICAL THERAPIST
14.4.3 NURSE
14.4.4 HEALTH COACH
14.4.5 OTHERS
14.5 REHABILITATION CENTERS
14.5.1 MULTIPLE
14.5.2 PHYSICAL THERAPIST
14.5.3 NURSE
14.5.4 HEALTH COACH
14.5.5 OTHERS
14.6 VIRTUAL/HOME HEALTH CARE SETTINGS
14.6.1 MULTIPLE
14.6.2 PHYSICAL THERAPIST
14.6.3 NURSE
14.6.4 HEALTH COACH
14.6.5 OTHERS
14.7 OTHERS
15 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION
15.1 ASIA-PACIFIC
15.1.1 CHINA
15.1.2 JAPAN
15.1.3 SOUTH KOREA
15.1.4 INDIA
15.1.5 AUSTRALIA
15.1.6 NEW ZEALAND
15.1.7 SINGAPORE
15.1.8 THAILAND
15.1.9 MALAYSIA
15.1.10 VIETNAM
15.1.11 TAIWAN
15.1.12 INDONESIA
15.1.13 PHILIPPINES
15.1.14 REST OF ASIA PACIFIC
16 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 HINGE HEALTH, INC
18.1.1 COMPANY SNAPSHOT
18.1.2 COMPANY SHARE ANALYSIS
18.1.3 PRODUCT PORTFOLIO
18.1.4 RECENT DEVELOPMENTS
18.2 SWORD HEALTH, INC
18.2.1 COMPANY SNAPSHOT
18.2.2 COMPANY SHARE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENT
18.3 OMADA HEALTHA INC.
18.3.1 COMPANY SNAPSHOT
18.3.2 COMPANY SHARE ANALYSIS
18.3.3 PRODUCT PORTFOLIO
18.3.4 RECENT DEVELOPMENT
18.4 KAIA HEALTH
18.4.1 COMPANY SNAPSHOT
18.4.2 COMPANY SHARE ANALYSIS
18.4.3 PRODUCT PORTFOLIO
18.4.4 RECENT DEVELOPMENTS
18.5 WELLNESS COACHES USA, LLC.
18.5.1 COMPANY SNAPSHOT
18.5.2 COMPANY SHARE ANALYSIS
18.5.3 PRODUCT PORTFOLIO
18.5.4 RECENT DEVELOPMENT
18.6 AIRROSTI REHAB CENTER, LLC
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENTS
18.7 DARIOHEALTH CORP. (2021)
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENTS
18.8 INCLUDEHEALTH (2021)
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 IMC (2021)
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 KIIO
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENT
18.11 LIMBER HEALTH, INC.
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENT
18.12 MOVEMENT RX (2021)
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
18.13 PHZIO (2021)
18.13.1 COMPANY SNAPSHOT
18.13.2 PRODUCT PORTFOLIO
18.13.3 RECENT DEVELOPMENT
18.14 RECOVERYONE
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENT
18.15 SPARTA SCIENCE
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENTS
18.16 SPRITE HEALTH
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENTS
18.17 SIMPLETHERAPY, INC.
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
表格列表
TABLE 1 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 2 ASIA PACIFIC DIGITAL BIOFEEDBACK SYSTEM IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 ASIA PACIFIC MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 ASIA PACIFIC MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 5 ASIA PACIFIC SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 ASIA PACIFIC SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 7 ASIA PACIFIC DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 8 ASIA PACIFIC POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 9 ASIA PACIFIC OTHERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 11 ASIA PACIFIC PRECISION MOTION TECHNOLOGY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 ASIA PACIFIC COMPUTER MOTION TECHNOLOGY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 ASIA PACIFIC OTHER TECHNOLOGIES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 15 ASIA PACIFIC PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 ASIA PACIFIC PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 17 ASIA PACIFIC TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 ASIA PACIFIC TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 19 ASIA PACIFIC COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 ASIA PACIFIC COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 21 ASIA PACIFIC OTHERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 23 ASIA PACIFIC VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 ASIA PACIFIC VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 25 ASIA PACIFIC IN-PERSON THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 ASIA PACIFIC CUSTOMIZED/ PERSONALIZED THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 ASIA PACIFIC OTHERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 29 ASIA PACIFIC PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 ASIA PACIFIC PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 31 ASIA PACIFIC HIP SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 32 ASIA PACIFIC KNEE SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 33 ASIA PACIFIC POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 34 ASIA PACIFIC POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 35 ASIA PACIFIC HIP SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 36 ASIA PACIFIC KNEE SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 37 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 38 ASIA PACIFIC PEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 ASIA PACIFIC PEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 40 ASIA PACIFIC ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 ASIA PACIFIC ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 42 ASIA PACIFIC GERIATRIC IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 ASIA PACIFIC GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 44 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 45 ASIA PACIFIC HOSPITALS & CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 ASIA PACIFIC HOSPITALS & CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 47 ASIA PACIFIC NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 48 ASIA PACIFIC NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 49 ASIA PACIFIC HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 50 ASIA PACIFIC HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 51 ASIA PACIFIC REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 52 ASIA PACIFIC REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 53 ASIA PACIFIC VIRTUAL/HOME HEALTH CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 54 ASIA PACIFIC VIRTUAL/HOME HEALTH CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 55 ASIA PACIFIC OTHERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 56 ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 57 ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 58 ASIA-PACIFIC DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 59 ASIA-PACIFIC DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
TABLE 60 ASIA-PACIFIC MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 61 ASIA-PACIFIC SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 62 ASIA-PACIFIC DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 63 ASIA-PACIFIC POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 64 ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 65 ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 66 ASIA-PACIFIC PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 67 ASIA-PACIFIC TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 68 ASIA-PACIFIC COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 69 ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 70 ASIA-PACIFIC VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 71 ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 ASIA-PACIFIC PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 73 ASIA-PACIFIC HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 ASIA-PACIFIC KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 75 ASIA-PACIFIC POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 76 ASIA-PACIFIC HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 77 ASIA-PACIFIC KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 78 ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 79 ASIA-PACIFIC PAEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 80 ASIA-PACIFIC ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 81 ASIA-PACIFIC GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 82 ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 83 ASIA-PACIFIC HOSPITALS AND CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 84 ASIA-PACIFIC NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 85 ASIA-PACIFIC HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 86 ASIA-PACIFIC REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 87 ASIA-PACIFIC VIRTUAL HOME CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 88 CHINA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 89 CHINA DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 90 CHINA DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
TABLE 91 CHINA MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 92 CHINA SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 93 CHINA DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 94 CHINA POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 95 CHINA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 96 CHINA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 97 CHINA PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 98 CHINA TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 99 CHINA COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 100 CHINA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 101 CHINA VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 102 CHINA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 103 CHINA PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 CHINA HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 105 CHINA KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 106 CHINA POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 107 CHINA HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 108 CHINA KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 109 CHINA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 110 CHINA PAEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 111 CHINA ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 112 CHINA GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 113 CHINA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 114 CHINA HOSPITALS AND CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 115 CHINA NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 116 CHINA HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 117 CHINA REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 118 CHINA VIRTUAL HOME CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 119 JAPAN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 120 JAPAN DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 121 JAPAN DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
TABLE 122 JAPAN MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 123 JAPAN SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 124 JAPAN DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 125 JAPAN POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 126 JAPAN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 127 JAPAN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 128 JAPAN PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 129 JAPAN TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 130 JAPAN COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 131 JAPAN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 132 JAPAN VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 133 JAPAN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 134 JAPAN PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 135 JAPAN HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 136 JAPAN KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 137 JAPAN POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 138 JAPAN HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 139 JAPAN KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 140 JAPAN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 141 JAPAN PAEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 142 JAPAN ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 143 JAPAN GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 144 JAPAN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 145 JAPAN HOSPITALS AND CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 146 JAPAN NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 147 JAPAN HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 148 JAPAN REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 149 JAPAN VIRTUAL HOME CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 150 SOUTH KOREA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 151 SOUTH KOREA DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 152 SOUTH KOREA DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
TABLE 153 SOUTH KOREA MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 SOUTH KOREA SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 155 SOUTH KOREA DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 156 SOUTH KOREA POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 157 SOUTH KOREA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 158 SOUTH KOREA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 159 SOUTH KOREA PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 160 SOUTH KOREA TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 161 SOUTH KOREA COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 162 SOUTH KOREA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 163 SOUTH KOREA VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 164 SOUTH KOREA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 165 SOUTH KOREA PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 166 SOUTH KOREA HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 167 SOUTH KOREA KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 168 SOUTH KOREA POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 169 SOUTH KOREA HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 170 SOUTH KOREA KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 171 SOUTH KOREA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 172 SOUTH KOREA PAEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 173 SOUTH KOREA ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 174 SOUTH KOREA GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 175 SOUTH KOREA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 176 SOUTH KOREA HOSPITALS AND CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 177 SOUTH KOREA NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 178 SOUTH KOREA HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 179 SOUTH KOREA REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 180 SOUTH KOREA VIRTUAL HOME CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 181 INDIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 182 INDIA DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 183 INDIA DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
TABLE 184 INDIA MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 185 INDIA SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 186 INDIA DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 187 INDIA POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 188 INDIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 189 INDIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 190 INDIA PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 191 INDIA TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 192 INDIA COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 193 INDIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 194 INDIA VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 195 INDIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 196 INDIA PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 197 INDIA HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 198 INDIA KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 199 INDIA POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 200 INDIA HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 201 INDIA KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 202 INDIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 203 INDIA PAEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 204 INDIA ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 205 INDIA GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 206 INDIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 207 INDIA HOSPITALS AND CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 208 INDIA NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 209 INDIA HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 210 INDIA REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 211 INDIA VIRTUAL HOME CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 212 AUSTRALIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 213 AUSTRALIA DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 214 AUSTRALIA DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
TABLE 215 AUSTRALIA MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 216 AUSTRALIA SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 217 AUSTRALIA DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 218 AUSTRALIA POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 219 AUSTRALIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 220 AUSTRALIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 221 AUSTRALIA PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 222 AUSTRALIA TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 223 AUSTRALIA COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 224 AUSTRALIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 225 AUSTRALIA VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 226 AUSTRALIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 227 AUSTRALIA PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 228 AUSTRALIA HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 229 AUSTRALIA KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 230 AUSTRALIA POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 231 AUSTRALIA HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 232 AUSTRALIA KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 233 AUSTRALIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 234 AUSTRALIA PAEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 235 AUSTRALIA ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 236 AUSTRALIA GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 237 AUSTRALIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 238 AUSTRALIA HOSPITALS AND CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 239 AUSTRALIA NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 240 AUSTRALIA HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 241 AUSTRALIA REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 242 AUSTRALIA VIRTUAL HOME CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 243 NEW ZEALAND DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 244 NEW ZEALAND DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 245 NEW ZEALAND DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
TABLE 246 NEW ZEALAND MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 247 NEW ZEALAND SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 248 NEW ZEALAND DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 249 NEW ZEALAND POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 250 NEW ZEALAND MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 251 NEW ZEALAND MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 252 NEW ZEALAND PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 253 NEW ZEALAND TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 254 NEW ZEALAND COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 255 NEW ZEALAND MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 256 NEW ZEALAND VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 257 NEW ZEALAND MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 258 NEW ZEALAND PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 259 NEW ZEALAND HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 260 NEW ZEALAND KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 261 NEW ZEALAND POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 262 NEW ZEALAND HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 263 NEW ZEALAND KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 264 NEW ZEALAND MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 265 NEW ZEALAND PAEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 266 NEW ZEALAND ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 267 NEW ZEALAND GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 268 NEW ZEALAND MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 269 NEW ZEALAND HOSPITALS AND CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 270 NEW ZEALAND NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 271 NEW ZEALAND HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 272 NEW ZEALAND REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 273 NEW ZEALAND VIRTUAL HOME CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 274 SINGAPORE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 275 SINGAPORE DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 276 SINGAPORE DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
TABLE 277 SINGAPORE MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 278 SINGAPORE SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 279 SINGAPORE DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 280 SINGAPORE POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 281 SINGAPORE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 282 SINGAPORE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 283 SINGAPORE PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 284 SINGAPORE TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 285 SINGAPORE COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 286 SINGAPORE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 287 SINGAPORE VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 288 SINGAPORE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 289 SINGAPORE PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 290 SINGAPORE HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 291 SINGAPORE KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 292 SINGAPORE POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 293 SINGAPORE HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 294 SINGAPORE KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 295 SINGAPORE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 296 SINGAPORE PAEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 297 SINGAPORE ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 298 SINGAPORE GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 299 SINGAPORE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 300 SINGAPORE HOSPITALS AND CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 301 SINGAPORE NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 302 SINGAPORE HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 303 SINGAPORE REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 304 SINGAPORE VIRTUAL HOME CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 305 THAILAND MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 306 THAILAND DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 307 THAILAND DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
TABLE 308 THAILAND MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 309 THAILAND SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 310 THAILAND DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 311 THAILAND POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 312 THAILAND MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 313 THAILAND MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 314 THAILAND PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 315 THAILAND TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 316 THAILAND COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 317 THAILAND MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 318 THAILAND VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 319 THAILAND MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 320 THAILAND PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 321 THAILAND HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 322 THAILAND KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 323 THAILAND POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 324 THAILAND HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 325 THAILAND KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 326 THAILAND MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 327 THAILAND PAEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 328 THAILAND ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 329 THAILAND GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 330 THAILAND MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 331 THAILAND HOSPITALS AND CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 332 THAILAND NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 333 THAILAND HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 334 THAILAND REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 335 THAILAND VIRTUAL HOME CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 336 MALAYSIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 337 MALAYSIA DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 338 MALAYSIA DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
TABLE 339 MALAYSIA MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 340 MALAYSIA SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 341 MALAYSIA DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 342 MALAYSIA POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 343 MALAYSIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 344 MALAYSIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 345 MALAYSIA PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 346 MALAYSIA TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 347 MALAYSIA COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 348 MALAYSIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 349 MALAYSIA VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 350 MALAYSIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 351 MALAYSIA PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 352 MALAYSIA HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 353 MALAYSIA KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 354 MALAYSIA POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 355 MALAYSIA HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 356 MALAYSIA KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 357 MALAYSIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 358 MALAYSIA PAEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 359 MALAYSIA ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 360 MALAYSIA GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 361 MALAYSIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 362 MALAYSIA HOSPITALS AND CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 363 MALAYSIA NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 364 MALAYSIA HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 365 MALAYSIA REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 366 MALAYSIA VIRTUAL HOME CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 367 VIETNAM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 368 VIETNAM DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 369 VIETNAM DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
TABLE 370 VIETNAM MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 371 VIETNAM SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 372 VIETNAM DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 373 VIETNAM POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 374 VIETNAM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 375 VIETNAM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 376 VIETNAM PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 377 VIETNAM TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 378 VIETNAM COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 379 VIETNAM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 380 VIETNAM VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 381 VIETNAM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 382 VIETNAM PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 383 VIETNAM HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 384 VIETNAM KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 385 VIETNAM POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 386 VIETNAM HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 387 VIETNAM KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 388 VIETNAM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 389 VIETNAM PAEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 390 VIETNAM ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 391 VIETNAM GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 392 VIETNAM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 393 VIETNAM HOSPITALS AND CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 394 VIETNAM NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 395 VIETNAM HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 396 VIETNAM REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 397 VIETNAM VIRTUAL HOME CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 398 TAIWAN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 399 TAIWAN DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 400 TAIWAN DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
TABLE 401 TAIWAN MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 402 TAIWAN SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 403 TAIWAN DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 404 TAIWAN POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 405 TAIWAN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 406 TAIWAN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 407 TAIWAN PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 408 TAIWAN TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 409 TAIWAN COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 410 TAIWAN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 411 TAIWAN VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 412 TAIWAN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 413 TAIWAN PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 414 TAIWAN HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 415 TAIWAN KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 416 TAIWAN POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 417 TAIWAN HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 418 TAIWAN KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 419 TAIWAN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 420 TAIWAN PAEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 421 TAIWAN ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 422 TAIWAN GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 423 TAIWAN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 424 TAIWAN HOSPITALS AND CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 425 TAIWAN NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 426 TAIWAN HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 427 TAIWAN REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 428 TAIWAN VIRTUAL HOME CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 429 INDONESIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 430 INDONESIA DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 431 INDONESIA DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
TABLE 432 INDONESIA MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 433 INDONESIA SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 434 INDONESIA DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 435 INDONESIA POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 436 INDONESIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 437 INDONESIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 438 INDONESIA PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 439 INDONESIA TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 440 INDONESIA COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 441 INDONESIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 442 INDONESIA VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 443 INDONESIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 444 INDONESIA PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 445 INDONESIA HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 446 INDONESIA KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 447 INDONESIA POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 448 INDONESIA HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 449 INDONESIA KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 450 INDONESIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 451 INDONESIA PAEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 452 INDONESIA ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 453 INDONESIA GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 454 INDONESIA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 455 INDONESIA HOSPITALS AND CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 456 INDONESIA NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 457 INDONESIA HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 458 INDONESIA REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 459 INDONESIA VIRTUAL HOME CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 460 PHILIPPINES MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 461 PHILIPPINES DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 462 PHILIPPINES DIGITAL BIOFEEDBACK SYSTEM MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
TABLE 463 PHILIPPINES MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 464 PHILIPPINES SOLUTIONS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 465 PHILIPPINES DIRECT SUPPORT IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY THERAPIES, 2021-2030 (USD MILLION)
TABLE 466 PHILIPPINES POST-OPERATIVE PAIN TRACKING IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 467 PHILIPPINES MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 468 PHILIPPINES MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 469 PHILIPPINES PHONE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 470 PHILIPPINES TABLET IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 471 PHILIPPINES COMPUTER IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE, 2021-2030 (USD MILLION)
TABLE 472 PHILIPPINES MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 473 PHILIPPINES VIRTUAL THERAPY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 474 PHILIPPINES MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 475 PHILIPPINES PRE-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 476 PHILIPPINES HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 477 PHILIPPINES KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 478 PHILIPPINES POST-SURGERY APPLICATION IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 479 PHILIPPINES HIP SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 480 PHILIPPINES KNEE SURGERY IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 481 PHILIPPINES MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 482 PHILIPPINES PAEDIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 483 PHILIPPINES ADULTS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 484 PHILIPPINES GERIATRICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 485 PHILIPPINES MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 486 PHILIPPINES HOSPITALS AND CLINICS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 487 PHILIPPINES NURSING HOMES IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 488 PHILIPPINES HEALTH CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 489 PHILIPPINES REHABILITATION CENTERS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 490 PHILIPPINES VIRTUAL HOME CARE SETTINGS IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PROVIDER TYPE, 2021-2030 (USD MILLION)
TABLE 491 REST OF ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 492 REST OF ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 493 REST OF ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE, 2021-2030 ASP (USD)
图片列表
FIGURE 1 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: GEOGRAPHIC SCOPE
FIGURE 3 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: DATA TRIANGULATION
FIGURE 4 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: SNAPSHOT
FIGURE 5 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BOTTOM-UP APPROACH
FIGURE 6 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: TOP-DOWN APPROACH
FIGURE 7 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: APPLICATION COVERAGE GRID
FIGURE 11 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: THE CATEGORY VS TIME GRID
FIGURE 12 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET SEGMENTATION
FIGURE 13 RISE IN AWARENESS ABOUT MUSCULOSKELETAL (MSK) DISEASES, GROWING PREVALENCE OF RHEUMATOID ARTHRITIS, TECHNOLOGICAL ADVANCEMENTS IN MUSCULOSKELETAL (MSK) DISEASES, AND STRATEGIC INITIATIVES BY MARKET PLAYERS ARE EXPECTED TO DRIVE THE MARKET GROWTH FOR ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 14 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET IN 2023 & 2030
FIGURE 15 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET : EPIDEMIOLOGY
FIGURE 16 PREVALENCE AND INCIDENCE OF RHEUMATOID ARTHRITIS
FIGURE 17 PREVALENCE AND INCIDENCE OF OSTEOARTHRITIS
FIGURE 18 PREVALENCE AND INCIDENCE OF OSTEOPOROSIS
FIGURE 19 PREVALENCE AND INCIDENCE OF PSORIATIC ARTHRITIS
FIGURE 20 PREVALENCE AND INCIDENCE OF ANKYLOSING SPONDYLITIS
FIGURE 21 INCIDENSE OF FIBROMYALGIA
FIGURE 22 PREVALENCE AND INCIDENCE OF TENDINITIS AND CARPEL TUNNEL SYNDROME
FIGURE 23 PREVALENCE AND INCIDENCE OF BONE FRACTURES
FIGURE 24 PREVALENCE AND INCIDENCE OF OSTEOMALACIA AND OSTEOPENIA
FIGURE 25 PREVALENCE AND INCIDENCE OF GOUT
FIGURE 26 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET
FIGURE 27 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY TYPE, 2022
FIGURE 28 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 29 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 30 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 31 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY TECHNOLOGY, 2022
FIGURE 32 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 33 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 34 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 35 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY INTEGRATION TYPE, 2022
FIGURE 36 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY INTEGRATION TYPE, 2023-2030 (USD MILLION)
FIGURE 37 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY INTEGRATION TYPE, CAGR (2023-2030)
FIGURE 38 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY INTEGRATION TYPE, LIFELINE CURVE
FIGURE 39 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY MODALITY, 2022
FIGURE 40 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY MODALITY, 2023-2030 (USD MILLION)
FIGURE 41 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY MODALITY, CAGR (2023-2030)
FIGURE 42 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 43 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY APPLICATION, 2022
FIGURE 44 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 45 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 46 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 47 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY PATIENT POPULATION, 2022
FIGURE 48 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY PATIENT POPULATION, 2023-2030 (USD MILLION)
FIGURE 49 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY PATIENT POPULATION, CAGR (2023-2030)
FIGURE 50 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY PATIENT POPULATION, LIFELINE CURVE
FIGURE 51 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY END USER, 2022
FIGURE 52 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 53 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY END USER, CAGR (2023-2030)
FIGURE 54 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 55 ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: SNAPSHOT (2022)
FIGURE 56 ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY COUNTRY (2022)
FIGURE 57 ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY COUNTRY (2023 & 2030)
FIGURE 58 ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY COUNTRY (2022 & 2030)
FIGURE 59 ASIA-PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: BY TYPE (2023-2030)
FIGURE 60 ASIA PACIFIC MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
